Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP842163.RA6BK_VQUY62zZNg_TofJPbZ_hwObKhGuaneIU-EdqIUE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP842163.RA6BK_VQUY62zZNg_TofJPbZ_hwObKhGuaneIU-EdqIUE130_assertion type Assertion NP842163.RA6BK_VQUY62zZNg_TofJPbZ_hwObKhGuaneIU-EdqIUE130_head.
- NP842163.RA6BK_VQUY62zZNg_TofJPbZ_hwObKhGuaneIU-EdqIUE130_assertion description "[Loss of TSLC1 expression was also observed in 20 of 46 (43%) human cancer cell lines, including those from esophageal (3 of 3), gastric (8 of 9), ovarian (2 of 5), endometrial (2 of 2), breast (1 of 3), colorectal (2 of 8) and small cell lung cancers (2 of 10).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP842163.RA6BK_VQUY62zZNg_TofJPbZ_hwObKhGuaneIU-EdqIUE130_provenance.
- NP842163.RA6BK_VQUY62zZNg_TofJPbZ_hwObKhGuaneIU-EdqIUE130_assertion evidence source_evidence_literature NP842163.RA6BK_VQUY62zZNg_TofJPbZ_hwObKhGuaneIU-EdqIUE130_provenance.
- NP842163.RA6BK_VQUY62zZNg_TofJPbZ_hwObKhGuaneIU-EdqIUE130_assertion SIO_000772 12925956 NP842163.RA6BK_VQUY62zZNg_TofJPbZ_hwObKhGuaneIU-EdqIUE130_provenance.
- NP842163.RA6BK_VQUY62zZNg_TofJPbZ_hwObKhGuaneIU-EdqIUE130_assertion wasDerivedFrom befree-20140225 NP842163.RA6BK_VQUY62zZNg_TofJPbZ_hwObKhGuaneIU-EdqIUE130_provenance.
- NP842163.RA6BK_VQUY62zZNg_TofJPbZ_hwObKhGuaneIU-EdqIUE130_assertion wasGeneratedBy ECO_0000203 NP842163.RA6BK_VQUY62zZNg_TofJPbZ_hwObKhGuaneIU-EdqIUE130_provenance.